Silencing TMED2 suppresses cell growth and tumor progression in diffuse large B-cell lymphoma via inducing G0/G1 cell cycle arrest - Top-Institutions - MDSpire

Silencing TMED2 suppresses cell growth and tumor progression in diffuse large B-cell lymphoma via inducing G0/G1 cell cycle arrest

  • By

  • Wei Qian

  • Mingzhen Yang

  • May 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    First Affiliated Hospital of Anhui Medical University
    First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui

    Key Differentiators

    • Hematology Oncology

  • #2

    Cell Bank of the Chinese Academy of Sciences
    Cell Bank of the Chinese Academy of Sciences

    Shanghai, Shanghai

    Key Differentiators

    • Hematology Oncology

  • #3

    University of Tsukuba
    University of Tsukuba

    Tsukuba, Ibaraki

    Key Differentiators

    • Hematology Oncology

  • #4

    CALGB/Alliance
    CALGB/Alliance

    Chicago, Illinois

    Key Differentiators

    • Hematology Oncology

Original Source(s)

Silencing TMED2 suppresses cell growth and tumor progression in diffuse large B-cell lymphoma via inducing G0/G1 cell cycle arrest

  • by Wei Qian, Mingzhen Yang

  • May 1, 2026

Related Content

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications